Paul Moss

41 - 50 out of 198Page size: 10

Publications

  1. 2005
  2. Published

    A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival

    Azra Alvi, Belinda Austen, Victoria Weston, Judy Powell, Wenbin Wei, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 1 Jun 2005, In: Blood. 105, p. 4484-4491 8 p.

    Research output: Contribution to journal › Article

  3. Published

    The number of human peripheral blood CD4+ CD²⁵high regulatory T cells increases with age

    Fiona Clark, Naeem Khan, Ronjon Chakraverty, Uppinangady Nayak & Paul Moss, 1 Jun 2005, In: Clinical & Experimental Immunology. 140, p. 540-546 7 p.

    Research output: Contribution to journal › Article

  4. Published

    Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecule

    Naeem Khan, Andrew Hislop, Lee Garner, Alan Rickinson, Paul Moss & Benjamin Willcox, 1 Jun 2005, In: The Journal of Infectious Diseases. 191, 11, p. 1842-1853 12 p.

    Research output: Contribution to journal › Article

  5. Published

    Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

    Mark Cobbold, Naeem Khan, Lucinda Billingham, Ronjon Chakraverty, Charles Craddock & Paul Moss, 1 Aug 2005, In: The Journal of Experimental Medicine. 202, 3, p. 379-386 8 p.

    Research output: Contribution to journal › Article

  6. Published

    Soluble Syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival

    Janet Dunn, Gulnaz Begum, Paul Moss, Mark Drayson & Dickens Pratt, 1 Aug 2005, In: British Journal of Haematology. 130, p. 542-548 7 p.

    Research output: Contribution to journal › Article

  7. Published

    Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation

    Mark Cook, David Briggs, Charles Craddock & Paul Moss, 13 Oct 2005, In: Blood. 107, 3, p. 1230-2 3 p.

    Research output: Contribution to journal › Article

  8. Published

    CD8+ T cells specific for cancer-germline gene antigens are found in many patients with multiple myeloma and their frequency correlates with disease burden

    Oliver Goodyear, Karen Piper, Naeem Khan, Dickens Pratt & Paul Moss, 15 Dec 2005, In: Blood. 106, p. 4217-4224 8 p.

    Research output: Contribution to journal › Article

  9. 2006
  10. Published

    Ageing is associated with a decline in peripheral blood CD56bright NK cells

    Naeem Khan, Tracey Chan, Uppinangady Nayak & Paul Moss, 1 Jan 2006, In: Immunity & Ageing. 3, 1, p. 10-

    Research output: Contribution to journal › Article

  11. Published

    Fusion vaccines induce epitope-specific cytotoxic CD8+ T cells against human leukaemia-associated minor histocompatibility antigens

    Karen Piper, Paul Moss, 1 Jan 2006, In: Cancer Research. 66, p. 5436-5442 7 p.

    Research output: Contribution to journal › Article

  12. Published

    EBV-associated mononucleosis leads to long-term global deficit in T cell responsiveness to IL-15

    Delphine Sauce, Martin Larsen, John Curnow, Paul Moss, Andrew Hislop, Mike Salmon & Alan Rickinson, 1 Jul 2006, In: Blood. 108, p. 11-18 8 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...20 Next